Peer-Review Fraud Scheme Uncovered in China

The Chinese government finds almost 500 researchers guilty of misconduct in relation to a recent spate of retractions from a cancer journal.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

© BRYAN SATALINOAfter a sweeping research misconduct investigation, China’s Ministry of Science and Technology (MST) has found nearly 500 researchers guilty of engaging in a peer-review fraud scam. Announced late last week (July 27), MST’s findings indicate that 486 scientific paper authors engaged, to some degree, in a scheme to nominate either fictitious or paid peer reviewers who would write positive reviews of their manuscripts.

“We should eradicate the problem from its roots,” He Defang, director of MST’s regulatory division in Beijing, tells Science.

MST is meting out stiff penalties to the guilty researchers. These range from suspending their research projects and canceling grants to rescinding promotions or even harsher retribution. “They will face punishment according to the Communist Party of China discipline regulations and the regulations on personnel from public institutions,” He told Chinese news outlet Xinhua.

The nature of the scam is not unprecedented, with Chinese authors being accused of similar practices in the recent past.

The investigation was sparked by the retraction of 107 papers—many of which were authored by Chinese scientists and were published between 2012 and 2016—from Tumor Biology in April. The MST found that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours